0001477449-24-000147.txt : 20240604 0001477449-24-000147.hdr.sgml : 20240604 20240604160537 ACCESSION NUMBER: 0001477449-24-000147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cave James L. CENTRAL INDEX KEY: 0002019394 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 241017934 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 wk-form4_1717531528.xml FORM 4 X0508 4 2024-05-31 0 0001477449 Teladoc Health, Inc. TDOC 0002019394 Cave James L. C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 INTERIM CAO 0 Common Stock 2024-05-31 4 M 0 339 A 10787 D Common Stock 2024-05-31 4 M 0 1001 A 11788 D Common Stock 2024-05-31 4 M 0 383 A 12171 D Common Stock 2024-05-31 4 M 0 1162 A 13333 D Common Stock 2024-06-03 4 S 0 854 11.157 D 12479 D Restricted Stock Units 2024-05-31 4 M 0 339 0 D Common Stock 339 1017 D Restricted Stock Units 2024-05-31 4 M 0 1001 0 D Common Stock 1001 0 D Restricted Stock Units 2024-05-31 4 M 0 383 0 D Common Stock 383 1534 D Restricted Stock Units 2024-05-31 4 M 0 1162 0 D Common Stock 1162 8139 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date. On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. /s/ Adam C. Vandervoort, Attorney-in-Fact 2024-06-04